Siemens Healthcare Chooses Cologne As The New Site For Its Molecular Diagnostics Rese
 

Siemens Healthcare has established new research laboratories for molecular diagnostics in Cologne, Germany. The focus of the research will be on "breast cancer", a disease that remains the number one cause of death among young women despite the large number of therapies currently available.

More...